Whitehawk Therapeutics (WHWK) Asset Utilization Ratio (2020 - 2025)

Whitehawk Therapeutics (WHWK) has 6 years of Asset Utilization Ratio data on file, last reported at 0.04 in Q4 2025.

• Asset Utilization Ratio for Q4 2025 came in at 0.04, down 86.5% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.04 (down 86.5% YoY), and the FY2025 annual result was 0.06, down 74.79% from the prior year.
• Asset Utilization Ratio declined to 0.04 in Q4 2025 per WHWK's latest filing, from 0.08 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.98 in Q1 2021 and troughed at 0.04 in Q4 2025.
• A 5-year average of 0.2 and a median of 0.15 in 2022 frame the typical range for Asset Utilization Ratio.
• The sharpest annual moves came in 2021 and 2023: Asset Utilization Ratio slumped 89.85% in 2021, then surged 122.56% in 2023.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.09 in 2021, then decreased by 6.95% to 0.08 in 2022, then surged by 122.56% to 0.18 in 2023, then jumped by 86.06% to 0.33 in 2024, then tumbled by 86.5% to 0.04 in 2025.
• Business Quant data shows WHWK's Asset Utilization Ratio at 0.04 in Q4 2025, 0.08 in Q3 2025, and 0.1 in Q2 2025.